VU6001221 is a blood-brain barrier permeable Choline Transporter (CHT) inhibitor (IC50 = 270 nM). VU6001221 increases the likelihood of extracellular choline elevation activating synaptic alpha7 nicotine ACh receptors. VU6001221 attenuates potassium-induced ACh levels in the prefrontal cortex[1][2].
Molecular Weight:
391.89
CAS Number:
[2002495-17-0]
Formula:
C20H26ClN3O3
Target:
Others
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
